Vol 31, No 1 (2024)
Original Article
Published online: 2022-02-18

open access

Page views 1766
Article views/downloads 717
Get Citation

Connect on Social Media

Connect on Social Media

Comparison of successful versus failed percutaneous coronary intervention in patients with chronic total occlusion: A systematic review and meta-analysis

Dongfeng Zhang1, Nan Nan1, Yuguo Xue1, Mingduo Zhang1, Jinfan Tian1, Changzhe Chen1, Min Zhang1, Xiantao Song1
Pubmed: 35244196
Cardiol J 2024;31(1):15-23.


Background: The optimal treatment strategy of chronic total occlusion (CTO) is currently debated. This meta-analysis aimed to evaluate the long-term clinical outcomes of successful percutaneous coronary intervention (PCI) of CTO. Methods: Electronic databases were searched for studies comparing long-term outcomes between successful PCI in patients with CTO using drug-eluting stents and failed procedures. Meta-analysis was conducted with major adverse cardiac events (MACE) and all-cause mortality during the longest follow-up as endpoints. The combined hazard ratios (HRs) were applied to assess the correlation between successful CTO PCI and MACE/all-cause mortality. Results: Eight studies consisting of 6,211 patients published between 2012 and 2020 met our inclusion criteria, and the CTO PCI success rate was 81.2%. Patients in the failed group were much older, and more likely to have morbidities (hypertension and prior myocardial infarction), reduced left ventricular ejection fraction, and severe lesion characteristics (multivessel disease and moderate/severe calcification). Pooled results indicated that successful CTO PCI was significantly associated with prognosis. Compared to failed recanalization, patients receiving successful procedures had an improved MACE (HR: 0.50, 95% CI: 0.40–0.61, p < 0.001). Subgroup analyses further revealed the prognostic value of successful CTO PCI. However, no difference was observed regarding all-cause mortality (HR: 0.79, 95% CI: 0.61–1.02, p = 0.074). Conclusions: The present study showed that CTO recanalization was associated with improved long-term outcomes. However, randomized trials are needed to confirm the results due to the mismatch of baseline characteristics.

Article available in PDF format

View PDF Download PDF file


  1. Ybarra LF, Rinfret S, Brilakis ES, et al. Definitions and Clinical Trial Design Principles for Coronary Artery Chronic Total Occlusion Therapies: CTO-ARC Consensus Recommendations. Circulation. 2021; 143(5): 479–500.
  2. Christofferson RD, Lehmann KG, Martin GV, et al. Effect of chronic total coronary occlusion on treatment strategy. Am J Cardiol. 2005; 95(9): 1088–1091.
  3. Fefer P, Knudtson ML, Cheema AN, et al. Current perspectives on coronary chronic total occlusions: the Canadian Multicenter Chronic Total Occlusions Registry. J Am Coll Cardiol. 2012; 59(11): 991–997.
  4. Jeroudi OM, Alomar ME, Michael TT, et al. Prevalence and management of coronary chronic total occlusions in a tertiary Veterans Affairs hospital. Catheter Cardiovasc Interv. 2014; 84(4): 637–643.
  5. Werner GS, Gitt AK, Zeymer U, et al. Chronic total coronary occlusions in patients with stable angina pectoris: impact on therapy and outcome in present day clinical practice. Clin Res Cardiol. 2009; 98(7): 435–441.
  6. Tsai TT, Stanislawski MA, Shunk KA, et al. Contemporary incidence, management, and long-term outcomes of percutaneous coronary interventions for chronic coronary artery total occlusions: insights from the VA CART program. JACC Cardiovasc Interv. 2017; 10(9): 866–875.
  7. Claessen BE, Dangas GD, Weisz G, et al. Prognostic impact of a chronic total occlusion in a non-infarct-related artery in patients with ST-segment elevation myocardial infarction: 3-year results from the HORIZONS-AMI trial. Eur Heart J. 2012; 33(6): 768–775.
  8. Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation. 2011; 124(23): e574–e651.
  9. Neumann FJ, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019; 40: 87–165.
  10. Park JP, Han S, Sung KC, et al. Seven-year clinical outcomes of successful versus failed revascularization using drug-eluting stents for the treatment of coronary chronic total occlusion. J Invasive Cardiol. 2016; 28(6): 229–236.
  11. Borgia F, Viceconte N, Ali O, et al. Improved cardiac survival, freedom from MACE and angina-related quality of life after successful percutaneous recanalization of coronary artery chronic total occlusions. Int J Cardiol. 2012; 161(1): 31–38.
  12. Niccoli G, De Felice F, Belloni F, et al. Late (3 years) follow-up of successful versus unsuccessful revascularization in chronic total coronary occlusions treated by drug eluting stent. Am J Cardiol. 2012; 110(7): 948–953.
  13. Toma A, Gick M, Minners J, et al. Survival after percutaneous coronary intervention for chronic total occlusion. Clin Res Cardiol. 2016; 105(11): 921–929.
  14. Lee PH, Lee SW, Park HS, et al. Successful recanalization of native coronary chronic total occlusion is not associated with improved long-term survival. JACC Cardiovasc Interv. 2016; 9(6): 530–538.
  15. Wu KZ, Huang ZH, Zhong ZA, et al. Successful treatment of complex coronary chronic total occlusions improves midterm outcomes. Ann Transl Med. 2019; 7(9): 194.
  16. Xenogiannis I, Nikolakopoulos I, Krestyaninov O, et al. Impact of successful chronic total occlusion percutaneous coronary interventions on subsequent clinical outcomes. J Invasive Cardiol. 2020; 32(11): 433–439.
  17. Stojkovic S, Juricic S, Dobric M, et al. Improved propensity-score matched long-term clinical outcomes in patients with successful percutaneous coronary interventions of coronary chronic total occlusion. Int Heart J. 2018; 59(4): 719–726.
  18. van der Schaaf RJ, Vis MM, Sjauw KD, et al. Impact of multivessel coronary disease on long-term mortality in patients with ST-elevation myocardial infarction is due to the presence of a chronic total occlusion. Am J Cardiol. 2006; 98(9): 1165–1169.
  19. Bataille Y, Déry JP, Larose É, et al. Deadly association of cardiogenic shock and chronic total occlusion in acute ST-elevation myocardial infarction. Am Heart J. 2012; 164(4): 509–515.
  20. Werner GS, Surber R, Ferrari M, et al. The functional reserve of collaterals supplying long-term chronic total coronary occlusions in patients without prior myocardial infarction. Eur Heart J. 2006; 27(20): 2406–2412.
  21. Sachdeva R, Agrawal M, Flynn SE, et al. The myocardium supplied by a chronic total occlusion is a persistently ischemic zone. Catheter Cardiovasc Interv. 2014; 83(1): 9–16.
  22. Gutiérrez-Chico JL, Cortés C, Ayoub M, et al. Subintimal shift as mechanism for side-branch occlusion in percutaneous treatment of chronic total occlusions with bifurcation lesions. Cardiol J. 2021 [Epub ahead of print].
  23. Chu M, Martínez-Hervás-Alonso MÁ, Reisbeck B, et al. The yin-yang sign in the detection of subintimal hematoma with high-definition intravascular ultrasound. Cardiol J. 2020; 27(1): 81–82.
  24. Mashayekhi K, Behnes M. The role of intravascular ultrasound in the treatment of chronic total occlusion with percutaneous coronary intervention. Cardiol J. 2020; 27(1): 4–5.
  25. Guelker JE, Bufe A, Blockhaus C, et al. The atherogenic index of plasma and its impact on recanalization of chronic total occlusion. Cardiol J. 2020; 27(6): 756–761.
  26. Guelker JE, Blockhaus C, Bufe A, et al. In-hospital outcome of re-attempted percutaneous coronary interventions for chronic total occlusion. Cardiol J. 2021 [Epub ahead of print].
  27. Zhao Y, Peng H, Li X, et al. The impact of dissection and re-entry versus wire escalation techniques on long-term clinical outcomes in patients with chronic total occlusion lesions following percutaneous coronary intervention: An updated meta-analysis. Cardiol J. 2021; 28(3): 369–383.
  28. Shah A. Chronic total occlusion coronary intervention: in search of a definitive benefit. Methodist Debakey Cardiovasc J. 2018; 14(1): 50–59.
  29. Lee SW, Lee PH, Ahn JM, et al. Randomized trial evaluating percutaneous coronary intervention for the treatment of chronic total occlusion. Circulation. 2019; 139(14): 1674–1683.
  30. Werner GS, Martin-Yuste V, Hildick-Smith D, et al. A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions. Eur Heart J. 2018; 39(26): 2484–2493.
  31. Mashayekhi K, Nührenberg TG, Toma A, et al. A randomized trial to assess regional left ventricular function after stent implantation in chronic total occlusion: the REVASC trial. JACC Cardiovasc Interv. 2018; 11(19): 1982–1991.
  32. Abo-Aly M, Misumida N, Backer N, et al. Percutaneous coronary intervention with drug-eluting stent versus optimal medical therapy for chronic total occlusion: systematic review and meta-analysis. Angiology. 2019; 70(10): 908–915.